Researchers to Present Data on Soliris As A Treatment For Patients With aHUS At ASN 2014 Annual Meeting
October 23, 2014 at 16:26 PM EDT
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that researchers will present seven posters detailing findings from ...
